These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6423163)

  • 1. Water purification and the incidence of fractures in patients receiving home haemodialysis supervised by a single centre: evidence for "safe" upper limit of aluminium in water.
    Platts MM; Owen G; Smith S
    Br Med J (Clin Res Ed); 1984 Mar; 288(6422):969-72. PubMed ID: 6423163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water supply aluminium concentration, dialysis dementia, and effect of reverse-osmosis water treatment.
    Davison AM; Walker GS; Oli H; Lewins AM
    Lancet; 1982 Oct; 2(8302):785-7. PubMed ID: 6126664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis.
    Platts MM; Goode GC; Hislop JS
    Br Med J; 1977 Sep; 2(6088):657-60. PubMed ID: 902042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silicon and aluminium interactions in haemodialysis patients.
    Parry R; Plowman D; Delves HT; Roberts NB; Birchall JD; Bellia JP; Davenport A; Ahmad R; Fahal I; Altmann P
    Nephrol Dial Transplant; 1998 Jul; 13(7):1759-62. PubMed ID: 9681724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.
    Mazzeo-Farina A; Cerulli N
    Clin Chim Acta; 1985 Apr; 147(3):247-54. PubMed ID: 3995774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum aluminium level in the veneto chronic haemodialysis population: cross-sectional study on 1,026 patients.
    Piccoli A; Andriani M; Mattiello G; Nordio M; Modena F; Dalla Rosa C
    Nephron; 1989; 51(4):482-90. PubMed ID: 2787000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminium and fluoride in the water supply and their removal for haemodialysis.
    Cameron AP; Drury PJ; Harston GA; Ineson PR
    Sci Total Environ; 1988 Sep; 76(1):19-28. PubMed ID: 3238412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scalp hair as an indicator of aluminium exposure: comparison to bone and plasma.
    Wilhelm M; Passlick J; Busch T; Szydlik M; Ohnesorge FK
    Hum Toxicol; 1989 Jan; 8(1):5-9. PubMed ID: 2785480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminium in water for preparation of dialysate and in serum of dialysed patients.
    Blanusa M; Prester L; Crnogorac M; Puretić Z; Bubić-Filipi L; Dadić Z
    Arh Hig Rada Toksikol; 1997 Jun; 48(2):197-204. PubMed ID: 9434431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.
    Ward MK; Feest TG; Ellis HA; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8069):841-5. PubMed ID: 76795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminium toxicity during regular haemodialysis.
    Elliott HL; Dryburgh F; Fell GS; Sabet S; Macdougall AI
    Br Med J; 1978 Apr; 1(6120):1101-3. PubMed ID: 638617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM; Allen KR; Newton KE
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):51-4. PubMed ID: 15802033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.
    Fleming LW; Stewart Wk; Fell GS; Halls DJ
    Clin Nephrol; 1982 May; 17(5):222-7. PubMed ID: 7094439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysate aluminium concentration and renal bone disease.
    Walker GS; Aaron JE; Peacock M; Robinson PJ; Davison AM
    Kidney Int; 1982 Feb; 21(2):411-5. PubMed ID: 7070002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the value of plasma/serum aluminum in patients with chronic renal failure?
    Winney RJ; Cowie JF; Robson JS
    Clin Nephrol; 1985; 24 Suppl 1():S2-8. PubMed ID: 3842104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newcastle bone disease in Hong Kong: a study of aluminum associated osteomalacia.
    Chan MK; Varghese Z; Li MK; Wong WS; Li CS
    Int J Artif Organs; 1990 Mar; 13(3):162-8. PubMed ID: 2189835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium load in patients with analgesic nephropathy.
    Schwarz A; Kraft D; Keller F; Gawlik D; Offermann G
    Miner Electrolyte Metab; 1987; 13(3):141-6. PubMed ID: 3627045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute epidemic aluminium osteomalacia secondary to water supply contamination.
    O'Brien AA; Moore DP; Keogh JA
    Ir J Med Sci; 1990 Mar; 159(3):71-3. PubMed ID: 2361822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminium kinetics during haemodialysis with the Redy 2000 Sorbsystem.
    Curtis JR; Sampson B
    Int J Artif Organs; 1989 Nov; 12(11):683-7. PubMed ID: 2599666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.